Natera
Dr. Keen-Kim joined Natera to Direct the CLIA Laboratory in February 2018. After earning her B.S. from Carnegie Mellon and Ph.D. from MIT, Dr. Keen-Kim completed fellowships in clinical molecular genetics and clinical cytogenetics at UCLA, and is certified by the American Board of Medical Genetics and Genomics in both molecular and cytogenetics. Dr. Keen-Kim maintains clinical director licenses in CA and NY, and has expertise in building, validation, and process-improving clinical laboratory tests, including automating manual assays. Prior to Natera, Dr. Keen-Kim served in a variety of clinical, quality, regulatory and operational laboratory leadership roles at Color Genomics, Genoptix Medical Laboratory (a Novartis company), UCLA, and Quest Diagnostics.
This person is not in any offices
Natera
24 followers
Natera is a global leader in providing DNA testing across multiple clinical areas including women's health, organ health, and oncology. Where some set out to build a test, they set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment.